Percutaneous Device Closure of Patent Foramen Ovale in Patients With Presumed Cryptogenic Stroke or Transient Ischemic Attack The Mayo Clinic Experience

被引:29
作者
Ford, Monique A. [1 ]
Reeder, Guy S. [1 ]
Lennon, Ryan J. [2 ]
Brown, Robert D. [3 ]
Petty, George W. [3 ]
Cabalka, Allison K. [4 ]
Cetta, Frank [1 ,4 ]
Hagler, Donald J. [1 ,4 ]
机构
[1] Mayo Clin Coll Med, Div Cardiovasc Dis, Rochester, MN USA
[2] Mayo Clin Coll Med, Div Biostat, Rochester, MN USA
[3] Mayo Clin Coll Med, Div Neurol, Rochester, MN USA
[4] Mayo Clin Coll Med, Div Pediat Cardiol, Rochester, MN USA
关键词
patent foramen ovale; cryptogenic stroke; transient ischemic attack; ATRIAL SEPTAL ANEURYSM; PARADOXICAL EMBOLISM; RISK-FACTORS; ECHOCARDIOGRAPHY; CLASSIFICATION; PREVALENCE; DEFECT;
D O I
10.1016/j.jcin.2008.12.015
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives We sought to determine safety, recurrence rates, and novel risk factors for recurrence in patients with cryptogenic stroke/transient ischemic attack (TIA) after patent foramen ovale closure. Background Patent foramen ovale closure in patients with cryptogenic stroke/TIA remains highly controversial. There are limited data on long-term recurrence rates and their predictors in these patients. Methods The records of all patients who underwent patent foramen ovale device closure between December 2001 and June 2006 were reviewed. Patients were seen for clinical follow-up at 3 months then followed annually via telephone. Primary end points were recurrent stroke/TIA. Kaplan-Meier methods were used to estimate recurrent event rates. Cox regression analysis was used to identify risk factors for recurrences. Results There were 352 patients with cryptogenic stroke (n = 225) or TIA (n = 118) with a mean age of 53.4 years. The procedural complication rate was 3.4%. Recurrent events occurred in 8 patients: 7 strokes and 2 TIA, 1 patient had 2 recurrent strokes. The recurrence rate was 0.6% and 2.1% for stroke and 0.3% and 0.7% for TIA at 1 and 4 years, respectively. The combined end point of recurrent stroke/TIA occurred at a rate of 0.9% and 2.8% at 1 and 4 years, respectively. Risk factors for recurrences were elevated pulmonary artery pressure (hazard ratio [HR]: 1.12, p = 0.009), elevated right ventricular pressure (HR: 1.09, p = 0.04), factor V Leiden mutation (HR: 7.42, p = 0.014), and protein S deficiency (HR: 12.2, p = 0.002). Residual shunt and atrial septal aneurysm were not associated with recurrences. Conclusions Patent foramen ovale device closure is safe and is associated with a low recurrence of stroke/TIA. Factors associated with recurrence are thrombophilia and elevated intracardiac pressures. (J Am Coll Cardiol Intv 2009;2:404-11) (C) 2009 by the American College of Cardiology Foundation
引用
收藏
页码:404 / 411
页数:8
相关论文
共 29 条
[1]   CLASSIFICATION OF SUBTYPE OF ACUTE ISCHEMIC STROKE - DEFINITIONS FOR USE IN A MULTICENTER CLINICAL-TRIAL [J].
ADAMS, HP ;
BENDIXEN, BH ;
KAPPELLE, LJ ;
BILLER, J ;
LOVE, BB ;
GORDON, DL ;
MARSH, EE ;
KASE, CS ;
WOLF, PA ;
BABIKIAN, VL ;
LICATAGEHR, EE ;
ALLEN, N ;
BRASS, LM ;
FAYAD, PB ;
PAVALKIS, FJ ;
WEINBERGER, JM ;
TUHRIM, S ;
RUDOLPH, SH ;
HOROWITZ, DR ;
BITTON, A ;
MOHR, JP ;
SACCO, RL ;
CLAVIJO, M ;
ROSENBAUM, DM ;
SPARR, SA ;
KATZ, P ;
KLONOWSKI, E ;
CULEBRAS, A ;
CAREY, G ;
MARTIR, NI ;
FICARRA, C ;
HOGAN, EL ;
CARTER, T ;
GURECKI, P ;
MUNTZ, BK ;
RAMIREZLASSEPAS, M ;
TULLOCH, JW ;
QUINONES, MR ;
MENDEZ, M ;
ZHANG, SM ;
ALA, T ;
JOHNSTON, KC ;
ANDERSON, DC ;
TARREL, RM ;
NANCE, MA ;
BUDLIE, SR ;
DIERICH, M ;
HELGASON, CM ;
HIER, DB ;
SHAPIRO, RA .
STROKE, 1993, 24 (01) :35-41
[2]   Thrombus-in-transit and paradoxical embolism [J].
Aggarwal, K ;
Jayam, VK ;
Meyer, MA ;
Nayak, AK ;
Nathan, S .
JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY, 2002, 15 (09) :1021-1022
[3]   PARAMETERS AFFECTING OCCURRENCE OF PARADOXICAL AIR-EMBOLISM [J].
BLACK, S ;
CUCCHIARA, RF ;
NISHIMURA, RA ;
MICHENFELDER, JD .
ANESTHESIOLOGY, 1989, 71 (02) :235-241
[4]   Stroke recurrence in patients with patent foramen ovale: The Lausanne Study [J].
Bogousslavsky, J ;
Garazi, S ;
Jeanrenaud, X ;
Aebischer, N ;
VanMelle, G .
NEUROLOGY, 1996, 46 (05) :1301-1305
[5]   ATRIAL SEPTAL ANEURYSM AND PATENT FORAMEN OVALE AS RISK-FACTORS FOR CRYPTOGENIC STROKE IN PATIENTS LESS-THAN 55 YEARS OF AGE - A STUDY USING TRANSESOPHAGEAL ECHOCARDIOGRAPHY [J].
CABANES, L ;
MAS, JL ;
COHEN, A ;
AMARENCO, P ;
CABANES, PA ;
OUBARY, P ;
CHEDRU, F ;
GUERIN, F ;
BOUSSER, MG ;
DERECONDO, J .
STROKE, 1993, 24 (12) :1865-1873
[6]   Cardiogenic and aortogenic brain embolism [J].
Doufekias, Eleni ;
Segal, Alan Z. ;
Kizer, Jorge R. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (11) :1049-1059
[7]  
Fabricius Alex M, 2002, Asian Cardiovasc Thorac Ann, V10, P342
[8]   Patent foramen ovale and cryptogenic stroke in older patients [J].
Handke, Michael ;
Harloff, Andreas ;
Olschewski, Manfred ;
Hetzel, Andreas ;
Geibel, Annette .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (22) :2262-2268
[9]   DIAGNOSIS AND CLASSIFICATION OF ATRIAL SEPTAL ANEURYSM BY TWO-DIMENSIONAL ECHOCARDIOGRAPHY - REPORT OF 80 CONSECUTIVE CASES [J].
HANLEY, PC ;
TAJIK, AJ ;
HYNES, JK ;
EDWARDS, WD ;
REEDER, GS ;
HAGLER, DJ ;
SEWARD, JB .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1985, 6 (06) :1370-1382
[10]   Effect of medical treatment in stroke patients with patent foramen ovale - Patent foramen ovale in Cryptogenic Stroke Study [J].
Homma, S ;
Sacco, RL ;
Di Tullio, MR ;
Sciacca, RR ;
Mohr, JP .
CIRCULATION, 2002, 105 (22) :2625-2631